Genetic-Effects Study of Radiation Should Help Clarify Radiation Exposure in Cancer Survivors and Their Offspring
|
By MedImaging International staff writers Posted on 27 Oct 2009 |
Researchers are initiating a large international study on the possible genetic effects of radiation and cancer drug exposures on future generations.
The study's lead investigators met in October 2009 at the University of Oklahoma (OU) Health Sciences Center (Oklahoma City, USA) to discuss their recent findings, which will be presented at an upcoming meeting of the American Society of Human Genetics. The study, which combines cancer survivors in the United States and Scandinavia, is looking at potential genetic consequences of reproductive organs exposed to curative therapy by drugs or radiation. Scientists want to determine whether radiation and chemotherapy before conception increases the occurrence of birth defects, stillbirths, and specific conditions such as Down's syndrome. They also want to know if radiation treatment leads to cancer or DNA damage in the patients' offspring. It is the first and largest study of its kind.
In Denmark and Finland, researchers have been able to identify all cancer survivors since 1943 and 1952, respectively, who had cancer before age 35. They also documented the nearly 20,000 children produced by the survivors. Scientists now want to compare their findings with patients in the United States.
"So far, the results have been encouraging,” said John J. Mulvihill, M.D., one of the leaders of the study and a renowned geneticist at the OU College of Medicine and the OU Cancer Institute. "This study is important for many reasons, but most notably for cancer survivors who need reassurances that their children will not be affected by their chemotherapy and radiation treatment. This research also will help families in Hiroshima and Chernobyl where residents were exposed to high levels of radiation as children and young adults.”
In addition to the University of Oklahoma Health Sciences Center, seven top cancer research centers worldwide are participating in the study.
Related Links:
University of Oklahoma Health Sciences Center
The study's lead investigators met in October 2009 at the University of Oklahoma (OU) Health Sciences Center (Oklahoma City, USA) to discuss their recent findings, which will be presented at an upcoming meeting of the American Society of Human Genetics. The study, which combines cancer survivors in the United States and Scandinavia, is looking at potential genetic consequences of reproductive organs exposed to curative therapy by drugs or radiation. Scientists want to determine whether radiation and chemotherapy before conception increases the occurrence of birth defects, stillbirths, and specific conditions such as Down's syndrome. They also want to know if radiation treatment leads to cancer or DNA damage in the patients' offspring. It is the first and largest study of its kind.
In Denmark and Finland, researchers have been able to identify all cancer survivors since 1943 and 1952, respectively, who had cancer before age 35. They also documented the nearly 20,000 children produced by the survivors. Scientists now want to compare their findings with patients in the United States.
"So far, the results have been encouraging,” said John J. Mulvihill, M.D., one of the leaders of the study and a renowned geneticist at the OU College of Medicine and the OU Cancer Institute. "This study is important for many reasons, but most notably for cancer survivors who need reassurances that their children will not be affected by their chemotherapy and radiation treatment. This research also will help families in Hiroshima and Chernobyl where residents were exposed to high levels of radiation as children and young adults.”
In addition to the University of Oklahoma Health Sciences Center, seven top cancer research centers worldwide are participating in the study.
Related Links:
University of Oklahoma Health Sciences Center
Latest General/Advanced Imaging News
- New SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease
- Whole-Body PET/CT Tracks Metabolic Changes After Bariatric Surgery
- PET Tracer Localizes Overactive Adrenal Glands in Primary Aldosteronism
- Multimodal AI Tool Combines CT and Health Records to Predict Heart Risk
- AI Tool Automates Radiotherapy Planning for Cervical and Prostate Cancer
- New Proton Therapy Platform Integrates into Existing Radiotherapy Departments
- 3D-Printed Intraoral Device Enhances Head and Neck Radiotherapy Accuracy
- Molecular Imaging Agent Shows Promise for Endometriosis Detection and Monitoring
- Automated AI Tool Detects Early Pancreatic Cancer on Routine CT
- Routine Cardiac CT Enhanced to Predict Heart Failure Risk
- New Breast Imaging Viewer Unifies Modalities and Enhances Clinical Workflow
- Radiomics Analysis of CT Scans Enhances Evaluation of Sarcoidosis
- Hybrid AI System Improves Early Lung Cancer Detection on CT
- AI Tool Predicts Side Effects from Lung Cancer Treatment
- AI Tool Offers Prognosis for Patients with Head and Neck Cancer
- New 3D Imaging System Addresses MRI, CT and Ultrasound Limitations
Channels
Radiography
view channel
Rapid X-Ray Test Quantifies Pulmonary Regurgitation After Tetralogy of Fallot Repair
Tetralogy of Fallot is the most common cyanotic congenital heart defect and can leave patients with pulmonary valve regurgitation, a backward flow of blood into the right ventricle after repair.... Read more
AI Tool Flags Osteoporosis Risk from Routine Chest X-Rays
Osteoporosis is a progressive loss of bone density that is often silent until a fracture occurs. Current screening frameworks concentrate on older women and select high-risk groups. Many men, younger adults,... Read moreMRI
view channel
AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
Long acquisition times for advanced brain magnetic resonance imaging (MRI) can limit access, extend waiting lists, and disrupt clinical workflows. Reducing data requirements without sacrificing image fidelity... Read more
Cardiac MRI Measure Improves Risk Prediction in Tricuspid Regurgitation
Tricuspid regurgitation, in which blood flows back from the right ventricle into the right atrium, can lead to progressive right-sided heart failure. Clinicians need reliable ways to gauge severity and... Read moreUltrasound
view channelAI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
Echocardiography, an ultrasound examination of the heart, is central to diagnosing and managing cardiovascular disease. Many services struggle with limited availability of skilled sonographers, variable... Read more
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read moreNuclear Medicine
view channel
Targeted PET Platform Guides Osteosarcoma Resection and Margin Verification
Osteosarcoma, an aggressive primary bone cancer that mainly affects children and adolescents, demands wide excision to prevent local recurrence. Surgeons must achieve negative margins while preserving... Read more
Portable PET System Enables Real-Time Bedside Guidance for Biopsies and Ablations
Interventional radiology procedures typically rely on ultrasound, X-ray fluoroscopy, or computed tomography for image guidance. These modalities visualize anatomy but offer limited molecular information,... Read moreGeneral/Advanced Imaging
view channelNew SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease
Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read more
Whole-Body PET/CT Tracks Metabolic Changes After Bariatric Surgery
Obesity surgery improves weight and comorbidity profiles, yet clinicians lack tools to monitor organ-level metabolic recovery after the procedure. A clear view of systemic changes could refine follow-up... Read moreImaging IT
view channel
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







